1. Home
  2. BOLD vs SWIN Comparison

BOLD vs SWIN Comparison

Compare BOLD & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • SWIN
  • Stock Information
  • Founded
  • BOLD 2018
  • SWIN 2017
  • Country
  • BOLD United States
  • SWIN Hong Kong
  • Employees
  • BOLD N/A
  • SWIN N/A
  • Industry
  • BOLD
  • SWIN
  • Sector
  • BOLD
  • SWIN
  • Exchange
  • BOLD Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • BOLD 24.4M
  • SWIN 214.1M
  • IPO Year
  • BOLD 2024
  • SWIN 2023
  • Fundamental
  • Price
  • BOLD $1.19
  • SWIN $3.93
  • Analyst Decision
  • BOLD Buy
  • SWIN
  • Analyst Count
  • BOLD 3
  • SWIN 0
  • Target Price
  • BOLD $4.00
  • SWIN N/A
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • SWIN 208.1K
  • Earning Date
  • BOLD 08-11-2025
  • SWIN 08-21-2025
  • Dividend Yield
  • BOLD N/A
  • SWIN N/A
  • EPS Growth
  • BOLD N/A
  • SWIN N/A
  • EPS
  • BOLD N/A
  • SWIN N/A
  • Revenue
  • BOLD N/A
  • SWIN $3,316,000.00
  • Revenue This Year
  • BOLD N/A
  • SWIN $29.79
  • Revenue Next Year
  • BOLD N/A
  • SWIN $54.60
  • P/E Ratio
  • BOLD N/A
  • SWIN N/A
  • Revenue Growth
  • BOLD N/A
  • SWIN N/A
  • 52 Week Low
  • BOLD $1.00
  • SWIN $1.16
  • 52 Week High
  • BOLD $4.72
  • SWIN $4.40
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • SWIN 62.05
  • Support Level
  • BOLD N/A
  • SWIN $3.70
  • Resistance Level
  • BOLD N/A
  • SWIN $3.99
  • Average True Range (ATR)
  • BOLD 0.00
  • SWIN 0.35
  • MACD
  • BOLD 0.00
  • SWIN -0.03
  • Stochastic Oscillator
  • BOLD 0.00
  • SWIN 93.02

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

Share on Social Networks: